BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022

Rhea-AI Summary

BIOLASE, a leader in dental lasers, will announce its fourth quarter and full-year 2021 financial results on March 17, 2022, after market close. A conference call will be held at 4:30 p.m. ET to discuss the results and corporate updates. Interested participants can dial in from the U.S. and Canada at (888) 254-3590 or internationally at +1 (323) 794-2551, using Conference ID 9127979. A webcast will also be available on the BIOLASE Investor Events Page. An audio archive will remain accessible for 30 days.

FOOTHILL RANCH, Calif., March 3, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2021 financial and operating results on Thursday, March 17, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (888) 254-3590. For international participants outside the U.S./Canada, the dial-in number is +1 (323) 794-2551. For all callers, refer to the Conference ID 9127979. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 301 patented and 38 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus^®, Waterlase Express^™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE^®, Waterlase^®, and Waterlase iPlus^® are registered trademarks of BIOLASE, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-to-report-fourth-quarter-and-full-year-2021-results-on-march-17-2022-301494739.html

SOURCE BIOLASE, Inc.

FAQ

When will BIOLASE report its fourth quarter and full-year 2021 financial results?

BIOLASE will release its results on March 17, 2022, after the U.S. market close.

What time is the BIOLASE conference call scheduled for?

The BIOLASE conference call is scheduled for 4:30 p.m. ET on March 17, 2022.

How can I participate in the BIOLASE conference call?

Participants in the U.S. can call (888) 254-3590, while international participants should dial +1 (323) 794-2551.

Where can I find the live webcast of the BIOLASE conference call?

The live webcast can be accessed on the BIOLASE Investor Events Page.

Is there an archive available for the BIOLASE conference call?

Yes, an audio archive of the webcast will be available for 30 days on the BIOLASE website.